Double blind, randomized, parallel group, multicentre study to evaluate the effects of manidipine 20 mg vs. amlodipine 10 mg and the combination of manidipine 10 mg plus delapril 30 mg vs. amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure in hypertensive patients.

Trial Profile

Double blind, randomized, parallel group, multicentre study to evaluate the effects of manidipine 20 mg vs. amlodipine 10 mg and the combination of manidipine 10 mg plus delapril 30 mg vs. amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure in hypertensive patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2013

At a glance

  • Drugs Manidipine (Primary) ; Amlodipine; Delapril
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Acronyms MANTRA
  • Most Recent Events

    • 21 Jun 2010 Results reported at the 20th European Meeting on Hypertension.
    • 03 Feb 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top